||Registry of biomedical companies:
  [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Y] [Z] 811 active entries
Phone: +49 (351) 41730
Fax: +49 (351) 4173109
Cenix BioScience is a contract research organization focused on advanced applications of RNA interference (RNAi) for accelerating the discovery and validation of novel therapeutic drug targets and the analysis of drug mechanisms of action.
Since its inception in 1999, when Cenix founders first pioneered the high-throughput use of RNAi for genome-scale screening, the company has consistently led efforts to further develop this technology in combination with high-content phenotyping strategies using multi-parametric assays in cultured cell models covering a wide range of disease fields. These core capabilities are now complemented by microRNA-focused experimentation and in vivo applications of RNAi.
Cenix has built-up solid scientific and commercial track records, successfully advancing therapeutic programs for numerous major industry and academic partners through fully-customized, multi-staged projects designed to offer maximal scientific and strategic value with full data transparency and carefully minimizing risk. As such, Cenix is a mature and fully-proven industrial research partner, applying the highest of scientific best practices with a breadth and depth of RNAi expertise second to none worldwide.
Last update of this entry: November 04, 2011
Bookmark and Share this page (what is this?)
Social bookmarking allows users to save and categorise a personal collection of bookmarks and share them with others. This is different to using your own browser bookmarks which are available using the menus within your web browser.
Use the links below to share this article on the social bookmarking site of your choice.
Read more about social bookmarking at Wikipedia - Social Bookmarking